Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

Lignende værker

• Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study
  af: Hebert, Adelaide A., et al.
  Udgivet: (2020)
• Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials
  af: Pariser, David M., et al.
  Udgivet: (2018)
• A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
  af: Glaser, Dee Anna, et al.
  Udgivet: (2019)
• Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis
  af: Pariser, David M., et al.
  Udgivet: (2021)
• Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
  af: Lamb, Yvette N.
  Udgivet: (2019)